Autologous Bone Marrow Derived MSCs
- Generic Name
- Autologous Bone Marrow Derived MSCs
Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction
Phase 2
Completed
- Conditions
- Acute Myocardial Infarction
- Interventions
- Drug: Control group
- First Posted Date
- 2011-07-12
- Last Posted Date
- 2011-07-12
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 80
- Registration Number
- NCT01392105
- Locations
- 🇰🇷
Yonsei University Wonju College of Medicine, Wonju Christian Hospital, Wonju, Gangwon-do, Korea, Republic of
🇰🇷Yonsei Cardiovascular Center and Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of
🇰🇷Inha University Hospital, Inchon, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath